|
2025
|
Invention
|
Apoe genotyping in cancer prognostics and treatment.
This disclosure presents methods and reagen... |
|
2024
|
Invention
|
Formulations with improved stability.
Formulations containing pharmaceutically active compounds ... |
|
|
Invention
|
Methods of treating cancer.
The invention features methods of treating cancer with β-GPA. The di... |
|
|
Invention
|
Compositions and methods for inhibiting creatine transport as a treatment for cancer.
The disclo... |
|
2023
|
Invention
|
Metal salts and uses thereof. The present invention relates to metal salts of 2-[3-[(3R)-3-[[2-ch... |
|
2022
|
Invention
|
Anti-mertk agonistic antibodies and uses thereof. The present disclosure provides antibody-drug c... |
|
|
Invention
|
Compositions and methods for inhibiting creatine transport as a treatment for cancer. e.g.e.g.e.g... |
|
|
Invention
|
Mertk peptides and uses thereof.
The present disclosure provides peptides comprising amino acid ... |
|
|
Invention
|
Mertk peptides and uses thereof. The present disclosure provides peptides comprising amino acid s... |
|
|
P/S
|
Drug and drug target discovery platform assaying micro-RNA expression for the identification of d... |
|
2021
|
Invention
|
High-affinity anti-mertk antibodies and uses thereof. The present disclosure provides antibodies ... |
|
|
P/S
|
Pharmaceuticals for the treatment of cancer; cancer
therapeutics. Research and development in th... |
|
|
P/S
|
Pharmaceutical products for the treatment of cancer; cancer therapeutics, namely, anti-cancer pre... |
|
2020
|
Invention
|
Methods of treating cancer. The invention features methods of treating cancer with β-GPA. The dis... |
|
|
Invention
|
Methods of treating cancer.
The invention features methods of treating cancer with 2-[3-[(3R)-3-... |
|
2019
|
Invention
|
Pharmaceutically acceptable salts of beta-guanidinopropionic acid with improved properties and us... |
|
|
Invention
|
Inhibitors of creatine transport and uses thereof. This invention relates to compounds that inhib... |
|
2018
|
Invention
|
Polymorphs and uses thereof. The present invention relates to new polymorphs of LXRβ agonists whi... |
|
|
Invention
|
Formulations with improved stability. Formulations containing pharmaceutically active compounds w... |
|
2017
|
Invention
|
Pharmaceutically acceptable salts of b-guanidinopropionic acid with improved properties and uses ... |
|
2015
|
Invention
|
Lxr agonists and uses thereof. This invention features compounds that modulate the activity of li... |
